A study using Cytosponge to find Barrett’s oesophagus and early oesophageal cancer (DELTA)

This study is using the Cytosponge test to identify who might have a higher risk of developing Barrett’s oesophagus and oesophageal cancer.

It is open to people who:

• are getting repeat prescriptions for heartburn and indigestion medicine

• have ongoing heartburn and indigestion and are going to have an endoscopy

• have been previously diagnosed with Barrett’s oesophagus and are on a surveillance programme